Group 1 - Modern Dental repurchased 100,000 shares at an average price of HKD 4.36 per share, totaling approximately HKD 436,200, with a cumulative repurchase of 5.927 million shares this year, representing 0.63% of the total share capital [1] - The stock price of Modern Dental increased by 1.64% to HKD 4.35 per share at the close of the Hong Kong stock market on the same day [1] - The company's stock repurchase actions indicate confidence in its financial health and suggest that the stock may be undervalued in the market, potentially attracting more investors and enhancing market confidence in the company's future [1] Group 2 - Modern Dental is a publicly listed company in Hong Kong, focusing on the dental sector, with a broad business layout in the research, production, and sales of dental products [2] - The company's product range includes dentures, dental equipment, and related dental materials, showcasing competitive advantages in quality and aesthetics [2] - The dental market is expected to grow due to increasing awareness of oral health, and Modern Dental is positioned to develop further in this favorable market environment while optimizing its capital structure through stock repurchases [2]

Core Insights - Henry Schein reported $3.17 billion in revenue for Q1 2025, a slight year-over-year decline of 0.1% [1] - The EPS for the quarter was $1.15, up from $1.10 a year ago, indicating a positive trend in earnings [1] - The revenue fell short of the Zacks Consensus Estimate of $3.23 billion by 1.84%, while the EPS exceeded the consensus estimate of $1.11 by 3.60% [1] Revenue Performance - Geographic Revenue from International Dental Equipment was $197 million, below the average estimate of $209.20 million [4] - U.S. Distribution Revenue for Dental Equipment was $187 million, significantly lower than the estimated $232.79 million, reflecting a 25.4% decline year-over-year [4] - International Dental Merchandise revenue was $594 million, also below the estimate of $608.26 million [4] - U.S. Distribution Medical revenue was $1.03 billion, slightly above the estimate of $1.01 billion, showing a year-over-year increase of 1.6% [4] - International Dental revenue was $798 million, under the estimate of $824.47 million, with a year-over-year decline of 1.6% [4] - U.S. Distribution Dental Merchandise revenue was $591 million, exceeding the estimate of $569.68 million [4] - Global Specialty Products net sales were $367 million, slightly above the average estimate of $364.59 million [4] Stock Performance - Henry Schein's shares returned -0.3% over the past month, contrasting with the Zacks S&P 500 composite's +0.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]